Cedars-Sinai Medical Center, Los Angeles, U.S.
Researchers from the United States provide details of new studies and findings in the area of brain cancer
Published in Mental Health Law Weekly, July 15th, 2006
Study 1: Brain cancer tumorigenesis could be inhibited by schwannomin.
"The neurofibromatosis 2 (NF2) tumor suppressor protein, schwannomin or merlin, is commonly lost upon NF2 gene mutation in benign human brain tumors. We identified the p110 subunit of the eukaryotic initiation factor 3 (eIF3c) as a schwannomin interacting protein," investigators in the United States reported.
"The eIF3 complex consists of approximately 10 subunits whose functions are only recently becoming known. Interaction between schwannomin and eIF3c suggests a role for schwannomin in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
More Articles from Mental Health Law Weekly
- Amarin
Amarin announces intention to list on AIM and IEX markets - Baylor College of Medicine, U.S.
Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice - BioMS Medical
European Journal of Neurology publishes MBP8298 Phase II and long-term follow-up data - University of Liege, Belgium
Junior physicians taught communication and stress management skills to deal with cancer patients - i3 Research
Antidepressant prescriptions in children decrease nearly 10% after warnings were issued - Aarhus University Hospital, Aarhus, Denmark
Preharvest CD34+ count correlates with total number of collected CD34+ cells/kg - More from this issue of Mental Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
